Integra Lifesciences Holdings (IART) Share-based Compensation Growth (1y) (2010 - 2026)
Integra Lifesciences Holdings (IART) Share-based Compensation Growth (1y) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.39 Bn | 174.10 Bn | 6.27 Bn | 9.69% |
| 2 | Stryker | 128.38 Bn | 125.50 Bn | 3.81 Bn | 37.62% |
| 3 | Medtronic | 107.68 Bn | 98.46 Bn | 6.41 Bn | 6.74% |
| 4 | Boston Scientific | 67.98 Bn | 66.53 Bn | 3.61 Bn | 12.16% |
| 5 | Edwards Lifesciences | 47.81 Bn | 44.13 Bn | 1.29 Bn | 12.94% |
| 6 | GE HealthCare Technologies | 28.53 Bn | 26.25 Bn | 1.98 Bn | 59.09% |
| 7 | Dexcom | 28.35 Bn | 27.24 Bn | 750.30 Mn | - |
| 8 | Smith & Nephew | 26.78 Bn | 26.20 Bn | - | - |
| 9 | Koninklijke Philips | 25.34 Bn | 22.21 Bn | 2.07 Bn | -30.44% |
| 10 | Integra Lifesciences Holdings | 1.57 Bn | 1.30 Bn | 216.98 Mn | -26.47% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -26.47% |
| Dec 31, 2025 | 0.74% |
| Sep 30, 2025 | 16.37% |
| Jun 30, 2025 | 506.17% |
| Mar 31, 2025 | -40.10% |
| Dec 31, 2024 | -56.69% |
| Sep 30, 2024 | -20.09% |
| Jun 30, 2024 | -22.12% |
| Mar 31, 2024 | -40.32% |
| Dec 31, 2023 | -90.71% |
| Sep 30, 2023 | -98.11% |
| Jun 30, 2023 | -97.28% |
| Mar 31, 2023 | -43.17% |
| Dec 31, 2022 | 113.53% |
| Sep 30, 2022 | -56.35% |
| Jun 30, 2022 | 253.53% |
| Mar 31, 2022 | 45.31% |
| Dec 31, 2021 | -267.59% |
| Sep 30, 2021 | 712.23% |
| Jun 30, 2021 | -148.14% |